Insider Ownership Filing for Cue Biopharma CEO

This filing reports on the insider ownership details for Shao-Lee Lin, the Chief Executive Officer and a Director of Cue Biopharma, Inc. (CUE). The report, filed on Form 3, indicates that Mr. Lin has no direct securities ownership as of April 30, 2026. The filing was signed on May 7, 2026. The address provided is C/O Cue Biopharma, Inc., 40 Guest Street, Boston, MA 02135.